Lupin DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.74×	0.78×	0.82×	0.80×	0.62×
	0.93×	0.92×	0.98×	0.93×	0.78×
	26.7%	26.6%	18.1%	13.1%	5.5%
	0.83×	0.83×	0.85×	0.85×	0.74×
	1.70×	1.70×	1.69×	1.67×	1.83×
	26.2%	27.1%	20.9%	13.7%	3.6%
	26.9%	26.9%	20.8%	14.3%	3.5%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

LUPIN₹1,989.90

Lupin Ltd.

· Pharma & Health

₹ CrorePeersSUNPHARMA CIPLA DRREDDY ALKEM FORTIS AUROPHARMA LAURUSLABS MANKINDMcap ₹90,978 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.62	0.80	0.82	0.78	0.74
Interest Burden (Pretax/EBIT) ×	0.78	0.93	0.98	0.92	0.93
EBIT Margin %	5.51	13.06	18.12	26.61	26.73
Asset Turnover ×	0.74	0.85	0.85	0.83	0.83
Financial Leverage (Assets/Equity) ×	1.83	1.67	1.69	1.70	1.70
ROE (5-step product, year-end total equity) %	3.64	13.73	20.90	27.09	26.20
ROE (owners' profit / average owners' equity) %	3.49	14.31	20.84	26.90	26.90

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.